Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | ...through January 7, 2028

Funding Amounts: Up to $50,000 direct costs per year, max 2 years (total $100,000 direct costs)

Summary: Supports small, basic experimental studies with humans (BESH) that meet both the NIH clinical trial and basic research definitions within the NICHD mission.

Key Information: Only applications proposing basic experimental studies with humans (not mechanistic, safety/efficacy, or observational studies) are eligible.